Pharmacology

Drug Development Psychoactive Substances Drug Mechanisms Drug Safety Drug Research Psychedelics GLP-1 Receptor Agonists Ketamine Hormones Drug Effects

Comprehensive Review Finds Five OTC Supplements Backed by Strong Depression Trials

The study grades evidence from 209 clinical trials of herbal and dietary products, exposing major gaps in safety reporting and research scope.

FDA Approves Bravecto Quantum Injectable for Year-Long Flea and Tick Prevention

Ketamine’s Party Popularity Masks Severe Health Risks

Texas Allocates $50 Million for Ibogaine Treatment Research

EU Drug Agency Flags Surge in Synthetic Substances and Rising Mortality

Australia Subsidizes Esketamine Spray for Treatment-Resistant Depression

Landmark Study Highlights Medical Cannabis’s Role in Cancer Care

Widespread Use of Weight-Loss Drugs Redefines Health, Beauty, and Access

Elon Musk’s Ketamine Use Raises Questions About His Behavior and Leadership

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

GLP-1 Weight Loss Drugs Surge in Popularity Amidst Stigma and Cultural Shifts

Chinese Zoo Faces Backlash for Selling Tiger Urine as Arthritis Remedy

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

Merck Secures $2 Billion Deal for Experimental Oral Weight Loss Drug from Hansoh Pharma

VA Launches First Psychedelic Therapy Study in Over 50 Years to Address PTSD in Veterans

NHS Rolls Out Varenicline to Help Smokers Quit

Cannabinol Found to Enhance Sleep Quality in New Study

Limited Access to Popular Weight-Loss Drugs Highlights Socioeconomic Disparities

Eli Lilly Fights Back Against Compounded Tirzepatide Amid FDA Supply Resolution

Organon Acquires Dermavant from Roivant for Up to $1.2 Billion